News-Medical.Net on MSN

One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial

In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...

Scientists have edited a gene that may reduce high cholesterol permanently

With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for ...